DocuSign, Inc. <DOCU.O>: Citigroup raises target price to $72 from $54
DOCU•Related News
Roivant Announces Positive Results From PHocus Study Of Mosliciguat In Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) And Unveils Ongoing Phase 3 PHrontier Study
ROIV•
Galmed regains Nasdaq compliance with $1 minimum bid price rule
GLMD•
NIQ expands Product Insights across Western Europe
NIQ•
MKDWELL management says H1 2026 revenue rises 12.9% on new technical services income
MKDW•
ABM FY26 Q3 net income rises 19% to $49.7 million; revenue increases 4.2% to $2.3 billion
ABM•